E-Learning Center
Join Our Network
OncoFacts

Follow Imedex on Twitter

Register for an upcoming conference!

Phone: +1 (678) 242 0906
registration@imedex.com

Febrile Neutropenia


Register Now

12th International Symposium on Febrile Neutropenia

12 - 13 March 2010

Luxembourg, Luxembourg

 

Continuing Medical Education

 

Who Should Attend

This educational activity is designed for medical oncologists, infectious disease specialists, hematologists, hospitalists, and other physicians, physicians-in-training, and healthcare professionals interested and/or involved in the care of patients with febrile neutropenia.

Objectives

Upon completion of this activity, participants should be able to:

  • Discuss and evaluate the clinical use of prophylactic versus empiric or preemptive therapy of fungal infections in febrile neutropenic patients
  • Discuss the appropriate selection and practical utilization of replacement antibiotics for therapy of infections caused by resistant bacteria in febrile neutropenic patients
  • Describe the role of native immunity on susceptibility and severity of infection in patients with febrile neutropenia
  • Identify and assess management strategies for infections in patients undergoing stem cell transplant from alternative sources and donors
  • Compare current and emerging therapies in the prevention and management of patients with febrile neutropenia

Elias Anaissie, MD
University of Arkansas School of Medical Sciences
Little Rock, Arkansas, United States

Mickael Aoun, MD
Jules Bordet Institute
Brussels, Belgium

Nicole Blijlevens, MD
St. Raboud University Medical Center
Nijmegen, The Netherlands

Catherine Cordonnier, MD
Hôpital Henri Mondor
Créteil, France

Mario Dicato, MD
Luxembourg Medical Center
Luxembourg, Luxembourg

J. Peter Donnelly, PhD
St. Raboud University Medical Center
Nijmegen, The Netherlands

Aspasia Georgala, MD
Jules Bordet Institute
Brussels Belgium

Jean A. Klastersky, MD, PhD
Jules Bordet Institute
Brussels, Belgium

Ofer Levy, MD, PhD
Harvard Medical School
Boston, Massachusetts, United States

Louis B. Rice, MD
Louis Stokes Cleveland
VA Medical Center
Cleveland, Ohio, United States

Jaime Sanz, MD
University Hospital La Fe
Valencia, Spain

Miguel A. Sanz, MD, PhD
University Hospital La Fe
Valencia, Spain

Wilfried A. M. Schroyens MD, PhD
University Hospital Antwerp
Antwerp, Belgium

Thomas J. Walsh, MD
National Cancer Institute
Bethesda, Maryland, United States

John R. Wingard, MD
University of Florida
Gainesville, Florida, United States

Friday, 12 March 2010

8:00
Introduction

Session I: Prophylactic versus empiric or preemptive therapy of fungal infections
Chair: J. Peter Donnelly, PhD
Co-Chair: Nicole Blijlevens, MD

8:10
State-of-the art lecture: Pre-emptive versus empirical anti-fungal therapy in neutropenic cancer patients
Catherine Cordonnier, MD

8:55
Discussion

9:10
Break

9:30
Oral abstracts

10:20
Case presentation
Thomas J. Walsh, MD

11:10
Session chair’s summary
J. Peter Donnelly, PhD

11:15
Lunch break

Session II: Replacement antibiotics for therapy of infections caused by resistant bacteria
Chair: Jean A. Klastersky, MD, PhD
Co-Chair: Wilfried A. M. Schroyens MD, PhD

13:30
State-of-the art lecture: Treatment of antibiotic-resistant bacteria: A major challenge for the next decade
Louis B. Rice, MD

14:15
Discussion

14:30
Break

14:50
Oral abstracts

15:40
Case presentation:
Mickael Aoun, MD and Aspasia Georgala, MD

16:30
Session Chair’s summary
Jean A. Klastersky, MD, PhD

16:40
Adjourn

Saturday, 13 March 2010

8:00
Welcome and introduction to day two
Mario Dicato, MD

Session III: The role of native immunity on susceptibility and severity of infection
Chair: John R. Wingard, MD
Co-Chair: Mario Dicato, MD

8:10
State-of-the art lecture: Why do some neutropenic patients get sick and others do not? The role of innate immunity polymorphisms
Elias Anaissie, MD

8:55
Discussion

9:10
Break

9:30
Oral abstracts

10:20
Case presentation
Ofer Levy, MD, PhD

11:10
Session chair’s summary
John R. Wingard, MD

11:15
Lunch break

Session IV: Infections related to alternative transplant procedures
Chair: Miguel A. Sanz, MD, PhD
Co-Chair: John R. Wingard, MD

13:30
State-of-the art lecture: Infections in patients undergoing stem cell transplant from alternative sources and donors
Miguel A. Sanz, MD, PhD

14:15
Discussion

14:30
Break

14:50
Oral abstracts

15:40
Case presentation:
Jaime Sanz, MD

16:30
Session Chair’s summary
Miguel A. Sanz, MD, PhD

16:40
Adjourn with summary by Chair and Local Chair
Jean A. Klastersky, MD, PhD and Mario Dicato, MD

Call for Abstracts

Participants interested in presenting data should first register or log in, then submit abstracts online by 19 January 2010. Abstracts are subject to acceptance by the Scientific Committee.

 

Abstract Guidelines

• Follow the online instructions
• Abstracts must be written in English
• Accepted format: Word document format, 9 point Arial font, 500 word count limit
• Use a concise title
• List affiliations of author(s) as briefly as possible, with city, state and country
• Place an asterisk (*) before the name of the presenting author
• Use standard and well-accepted abbreviations
• When using references, use standard and well-accepted formats
• Abstract content should be single-spaced, typed in lower case and contain:

  – Purpose of the study
– Summarized description of the project
– Results and conclusions

 

Submission Deadline - Extended!
19 January 2010

Registration Fees

Discounted
Payment received by 19 January 2010

€550

Regular
Payment received by 4 March 2010

€625

Full
Payment received after 4 March 2010

€695

Nurses/Residents/Students
Proof of eligibility must accompany registration

€200

 

To Register: You may register online by 4 March 2010, or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment: To pre-register, registration and payment must be received no later than 4 March 2010. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, congress materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 4 March 2010. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 4 March 2010.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

 

The Registration and Information Desk will be staffed:
Friday, 12 March 2010 7:00 – 16:40
Saturday, 13 March 2010 7:00 – 16:40

 

Italian Participants
Alijet & Fargo International SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Alijet & Fargo International SRL
Via Pietro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

Le Royal Luxembourg
12, boulevard Royal
L-2449 Luxembourg, Luxembourg
Tel.: +352 24 16 16 1
Fax: + 352 22 59 48
www.hotelroyal.lu

Following the lines of the purest hotel traditions, the hotel «Le Royal» welcomes you to its 210 rooms and suites, all of which are spacious, elegant and entirely air-conditioned. Their layout has been arranged to respond to the needs and comfort of an international business and tourist clientele.

For the convenience of attendees, a limited number of rooms have been reserved until 12 February 2010 at a discounted rate of €200.00 for single occupancy or €227.00 for double occupancy. These rates include buffet breakfast, city tax, service and V.A.T. This rate is not guaranteed outside the Congress dates or after 12 February 2010.

To reserve your room please contact the Le Royal Luxembourg reservations department at +352 24 16 16 1 or visit the hotel’s website at https://reservations.ihotelier.com/crs/g_login.cfm?hotelID=6019. To receive the group rate, callers must identify themselves as being with the 12th International Symposium on Febrile Neutropenia group. Internet users must enter the meeting promotional code: Imedex_March2010. The promotional code is case sensitive. The website is for new reservations only. If you need to change or cancel your reservation please call the hotel directly. Reservation requests received after 12 February 2010 may not be guaranteed the group rate.

Letter from the Chair

Dear Colleagues,
It is my pleasure to invite you to the 12th International Symposium on Febrile Neutropenia. For this winter’s meeting, we are delighted to be gathering in the capital city of the Grand Duchy of Luxembourg - a small country of great attractions at the very heart of Europe. We hope you will be able to join us for what is sure to be a rewarding and dynamic experience, as your perspectives and contributions add immeasurable value to this international symposium.

This scientific meeting is designed to provide medical oncologists, infectious disease specialists, and other interested healthcare professionals with the most salient aspects of the etiology, diagnosis, and state-of-the-art management of febrile neutropenia.

Topics are selected each year from recent developments in the field, current controversies and complicated cases. The highly interactive format includes 4 sessions; each comprised of a state of the art presentationlecture, followed by a cutting-edge research presentations relating to the topic, a case discussion focusing on the practical application of the topic, and a summary. There is always opportunity for extensive discussion of the presented data.

We will again be accepting abstracts for both oral and poster presentations and encourage you to submit your work by the 15 December deadline. We look forward to reviewing and sharing your research findings with the community.

Attendees have offered high praise for the quality of the scientific program and the international panel of experts in the faculty, and they have stated that participation in this conference significantly enhances their knowledge of the implications and management of febrile neutropenia. We hope you will plan to join us this year.

Warmly, Jean A. Klastersky, MD, PhD

 

ORGANIZER

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

PDF Announcement

The following company has provided an educational grant in support of this conference:

Teva

 

 

 

 

 

Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.

Information coming soon.

The following companies will be exhibiting at this conference:

pfizer

merck

 

Opportunities are available to companies interested in exhibiting at this conference. For more information, please contact Cori Gunter at +1(678) 242 0712 or by email at c.gunter@imedex.com.